Globus Medical (GMED) Restructuring Costs (2015 - 2026)

Globus Medical (GMED) has reported Restructuring Costs for 12 consecutive years, with $11.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Restructuring Costs fell 66.58% year-over-year to $11.1 million; the trailing twelve-month figure through Jun 2026 stood at $25.6 million (down 43.51% YoY), and the FY2025 full-year result was $42.3 million, up 42.88% from the prior year.
• Restructuring Costs advanced to $11.1 million in Q2 2026 per GMED's latest filing, from $6.4 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $45.6 million in Q3 2023 and bottomed at -$2.7 million in Q3 2025.
• Historically, Restructuring Costs has averaged $9.8 million across 5 years, with a median of $5.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Restructuring Costs plunged 207.77% in 2022, then soared 7097.7% in 2023.
• Over 5 years, Restructuring Costs stood at $3.6 million in 2022, then soared by 330.65% to $15.6 million in 2023, then plunged by 62.41% to $5.9 million in 2024, then jumped by 84.84% to $10.8 million in 2025, then gained by 2.35% to $11.1 million in 2026.
• According to Business Quant data, Restructuring Costs over the past three periods registered $11.1 million, $6.4 million, and $10.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.